<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font22">and </span>
   <span class="font17">with </span>
   <span class="font15">for </span>
   <span class="font14">[]. </span>
   <span class="font14">patients </span>
   <span class="font13">infection </span>
   <span class="font13">risk </span>
   <span class="font13">COVID- </span>
   <span class="font12">rheumatoid </span>
   <span class="font12">treatment </span>
   <span class="font12">infections </span>
   <span class="font12">viral </span>
   <span class="font11">The </span>
   <span class="font11">{background </span>
   <span class="font11">increased </span>
   <span class="font11">management </span>
   <span class="font11">that </span>
   <span class="font11">been </span>
   <span class="font11">are </span>
   <span class="font11">disease </span>
   <span class="font11">associated </span>
   <span class="font11">from </span>
   <span class="font11">has </span>
   <span class="font11">margin </span>
   <span class="font11">{border-style </span>
   <span class="font11">this </span>
   <span class="font11">have </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">coronavirus </span>
   <span class="font11">respiratory </span>
   <span class="font11">drugs </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">pneumonia </span>
   <span class="font10">use </span>
   <span class="font10">effect </span>
   <span class="font10">severe </span>
   <span class="font10">virus </span>
   <span class="font10">which </span>
   <span class="font10">[,]. </span>
   <span class="font10">antiviral </span>
   <span class="font10">arthritis </span>
   <span class="font10">infectious </span>
   <span class="font10">more </span>
   <span class="font10">potential </span>
   <span class="font10">receptor </span>
   <span class="font10">ACE </span>
   <span class="font10">IL- </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">lung </span>
   <span class="font10">review </span>
   <span class="font10">serious </span>
   <span class="font10">therapy </span>
   <span class="font10">treated </span>
   <span class="font10">[], </span>
   <span class="font10">cohort </span>
   <span class="font10">demonstrated </span>
   <span class="font10">during </span>
   <span class="font10">even </span>
   <span class="font10">inflammatory </span>
   <span class="font10">inhibitors </span>
   <span class="font10">study </span>
   <span class="font10">clinical </span>
   <span class="font10">role </span>
   <span class="font10">these </span>
   <span class="font10">acute </span>
   <span class="font10">can </span>
   <span class="font10">cases </span>
   <span class="font10">chloroquine </span>
   <span class="font10">cytokine </span>
   <span class="font10">higher </span>
   <span class="font10">increase </span>
   <span class="font10">inhibition </span>
   <span class="font10">most </span>
   <span class="font10">other </span>
   <span class="font10">rate </span>
   <span class="font10">systematic </span>
   <span class="font10">than </span>
   <span class="font10">.â€".) </span>
   <span class="font10">HZV </span>
   <span class="font10">Rev./j.autrev... </span>
   <span class="font10">Rheum </span>
   <span class="font10">all </span>
   <span class="font10">arthritis: </span>
   <span class="font10">baricitinib </span>
   <span class="font10">biological </span>
   <span class="font10">both </span>
   <span class="font10">course </span>
   <span class="font10">current </span>
   <span class="font10">immune </span>
   <span class="font10">incidence </span>
   <span class="font10">into </span>
   <span class="font10">px; </span>
   <span class="font10">reported </span>
   <span class="font10">results </span>
   <span class="font10">type </span>
   <span class="font10">used </span>
   <span class="font10">was </span>
   <span class="font10">{font-family </span>
   <span class="font10">JAK </span>
   <span class="font10">able </span>
   <span class="font10">anti-viral </span>
   <span class="font10">autoimmune </span>
   <span class="font10">cells </span>
   <span class="font10">compared </span>
   <span class="font10">currently </span>
   <span class="font10">font-size </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">including </span>
   <span class="font10">infection. </span>
   <span class="font10">levels </span>
   <span class="font10">may </span>
   <span class="font10">not </span>
   <span class="font10">novel </span>
   <span class="font10">protein </span>
   <span class="font10">recently </span>
   <span class="font10">studies </span>
   <span class="font10">such </span>
   <span class="font10">tofacitinib </span>
   <span class="font10">(adjusted </span>
   <span class="font10">ARDS </span>
   <span class="font10">Clin </span>
   <span class="font10">Dis./annrheumdis-- </span>
   <span class="font10">Lond </span>
   <span class="font10">Rev </span>
   <span class="font10">activity </span>
   <span class="font10">addition, </span>
   <span class="font10">also </span>
   <span class="font10">analysis </span>
   <span class="font10">approved </span>
   <span class="font10">bDMARDs </span>
   <span class="font10">between </span>
   <span class="font10">conducted </span>
   <span class="font10">different </span>
   <span class="font10">diseases </span>
   <span class="font10">double; </span>
   <span class="font10">early </span>
   <span class="font10">enzyme </span>
   <span class="font10">evidence </span>
   <span class="font10">hospitalized </span>
   <span class="font10">human </span>
   <span class="font10">infected </span>
   <span class="font10">influenza </span>
   <span class="font10">inhibit </span>
   <span class="font10">interstitial </span>
   <span class="font10">one </span>
   <span class="font10">only </span>
   <span class="font10">population </span>
   <span class="font10">response </span>
   <span class="font10">showed </span>
   <span class="font10">spike </span>
   <span class="font10">still </span>
   <span class="font10">syndrome </span>
   <span class="font10">their </span>
   <span class="font10">viruses </span>
   <span class="font10">vitro </span>
   <span class="font10">AAK </span>
   <span class="font10">Elsevier </span>
   <span class="font10">IFN </span>
   <span class="font10">JAK/STAT </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Res </span>
   <span class="font10">[[], </span>
   <span class="font10">about </span>
   <span class="font10">against </span>
   <span class="font10">arthritisAnn </span>
   <span class="font10">arthritisArthritis </span>
   <span class="font10">available </span>
   <span class="font10">blockers </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">but </span>
   <span class="font10">characterized </span>
   <span class="font10">commonly </span>
   <span class="font10">control </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">critically </span>
   <span class="font10">damage </span>
   <span class="font10">data </span>
   <span class="font10">development </span>
   <span class="font10">disease-modifying </span>
   <span class="font10">due </span>
   <span class="font10">epidemic </span>
   <span class="font10">expression </span>
   <span class="font10">host </span>
   <span class="font10">kinase </span>
   <span class="font10">leading </span>
   <span class="font10">major </span>
   <span class="font10">mortality </span>
   <span class="font10">new </span>
   <span class="font10">now </span>
   <span class="font10">penetration </span>
   <span class="font10">retrospective </span>
   <span class="font10">signaling </span>
   <span class="font10">solid; </span>
   <span class="font10">storm </span>
   <span class="font10">strategy </span>
   <span class="font10">synthetic </span>
   <span class="font10">though </span>
   <span class="font10">under </span>
   <span class="font10">very </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">CRS </span>
   <span class="font10">Chinese </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">Clinical </span>
   <span class="font10">Drug </span>
   <span class="font10">Engl./s-()- </span>
   <span class="font10">However, </span>
   <span class="font10">IL-, </span>
   <span class="font10">Infect </span>
   <span class="font10">March </span>
   <span class="font10">NSAIDs </span>
   <span class="font10">RCTs </span>
   <span class="font10">RNA </span>
   <span class="font10">Since </span>
   <span class="font10">activity, </span>
   <span class="font10">adverse </span>
   <span class="font10">agents </span>
   <span class="font10">angiotensin </span>
   <span class="font10">anti-rheumatic </span>
   <span class="font10">biologic </span>
   <span class="font10">blockade </span>
   <span class="font10">bold </span>
   <span class="font10">cell </span>
   <span class="font10">centre </span>
   <span class="font10">characteristics </span>
   <span class="font10">chronic </span>
   <span class="font10">complex </span>
   <span class="font10">compounds </span>
   <span class="font10">confirmed </span>
   <span class="font10">considered </span>
   <span class="font10">courier; </span>
   <span class="font10">crucial </span>
   <span class="font10">csDMARDs </span>
   <span class="font10">cytokines </span>
   <span class="font10">drug </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">endocytosis </span>
   <span class="font10">experience </span>
   <span class="font10">further </span>
   <span class="font10">general </span>
   <span class="font10">greater </span>
   <span class="font10">hand, </span>
   <span class="font10">health </span>
   <span class="font10">high </span>
   <span class="font10">immunosuppressive </span>
   <span class="font10">important </span>
   <span class="font10">inhibitor </span>
   <span class="font10">interferon </span>
   <span class="font10">its </span>
   <span class="font10">knowledge </span>
   <span class="font10">literature </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">might </span>
   <span class="font10">observational </span>
   <span class="font10">observed </span>
   <span class="font10">ongoing </span>
   <span class="font10">overall </span>
   <span class="font10">patients, </span>
   <span class="font10">population-based </span>
   <span class="font10">possible </span>
   <span class="font10">protocols </span>
   <span class="font10">pt;} </span>
   <span class="font10">pulmonary </span>
   <span class="font10">receiving </span>
   <span class="font10">recommendations </span>
   <span class="font10">related </span>
   <span class="font10">release </span>
   <span class="font10">resource </span>
   <span class="font10">same </span>
   <span class="font10">secondary </span>
   <span class="font10">seems </span>
   <span class="font10">they </span>
   <span class="font10">two </span>
   <span class="font10">will </span>
   <span class="font10">â€" </span>
  </p>
 </body>
</html>
